CDKN1A and chronic myelogenous leukemia, BCR-ABL1 positive: From previous studies, expression of DNMT1 and CDKN1A showed a negative regulation mechanism on chronic myelogenous leukemia (Kaufman-Szymczyk et al., 2019).